Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3035941rdf:typepubmed:Citationlld:pubmed
pubmed-article:3035941lifeskim:mentionsumls-concept:C0043047lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:3035941lifeskim:mentionsumls-concept:C0597484lld:lifeskim
pubmed-article:3035941pubmed:issue6 Pt 2lld:pubmed
pubmed-article:3035941pubmed:dateCreated1987-7-15lld:pubmed
pubmed-article:3035941pubmed:abstractTextFree-flow micropuncture and clearance studies were conducted in male Sprague-Dawley rats to investigate the effects of alpha 2-adrenoceptor stimulation on Na+, K+, and water transport along the nephron. Intravenous infusion of the selective alpha 2-adrenoceptor agonist B-HT 933 at 1 mg X kg-1 X h-1 increased urinary flow rate from 16.2 +/- 3.6 to 84.8 +/- 11.9 microliter/min, fractional excretion of Na+ from 1.36 +/- 0.31 to 3.57 +/- 0.52%, and fractional excretion of K+ from 26.9 +/- 3.0 to 42.3 +/- 2.2%, The diuresis, saluresis, and kaliuresis were not the result of increases in glomerular filtration rate or mean arterial blood pressure. Urine osmolality decreased from 1,126 +/- 177 to 325 +/- 33 mosmol/kg water and in 8 of the 11 animals studied B-HT 933 decreased urine osmolality to hyposmotic levels, suggesting a possible interaction between the alpha 2-adrenoceptor agonist and vasopressin. The alpha 2-adrenoceptor antagonist yohimbine (0.25/mg bolus, iv) inhibited the diuresis, saliuresis, and kaliuresis. In micropuncture studies, B-HT 933 was without effect on single-nephron glomerular filtration rate or on Na+, K+, and water transport along the superficial proximal tubule, loop of Henle, or distal tubule. Thus stimulation of alpha 2-adrenoceptors increases Na+, K+, and water excretion by inhibiting tubule reabsorption of these substances at nephron sites beyond the superficial distal tubule, most likely by the collecting tubule.lld:pubmed
pubmed-article:3035941pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:languageenglld:pubmed
pubmed-article:3035941pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:citationSubsetIMlld:pubmed
pubmed-article:3035941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3035941pubmed:statusMEDLINElld:pubmed
pubmed-article:3035941pubmed:monthJunlld:pubmed
pubmed-article:3035941pubmed:issn0002-9513lld:pubmed
pubmed-article:3035941pubmed:authorpubmed-author:StantonBBlld:pubmed
pubmed-article:3035941pubmed:authorpubmed-author:GellaiMMlld:pubmed
pubmed-article:3035941pubmed:authorpubmed-author:PuglisiEElld:pubmed
pubmed-article:3035941pubmed:issnTypePrintlld:pubmed
pubmed-article:3035941pubmed:volume252lld:pubmed
pubmed-article:3035941pubmed:ownerNLMlld:pubmed
pubmed-article:3035941pubmed:authorsCompleteYlld:pubmed
pubmed-article:3035941pubmed:paginationF1016-21lld:pubmed
pubmed-article:3035941pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:meshHeadingpubmed-meshheading:3035941-...lld:pubmed
pubmed-article:3035941pubmed:year1987lld:pubmed
pubmed-article:3035941pubmed:articleTitleLocalization of alpha 2-adrenoceptor-mediated increase in renal Na+, K+, and water excretion.lld:pubmed
pubmed-article:3035941pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3035941pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3035941pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3035941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3035941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3035941lld:pubmed